Stage-matched conductive hydrogel with pH/ROS/MMP9 triple-responsive salidroside release for post-infarction myocardial repair

Myocardial infarction (MI) triggers massive cardiomyocyte loss, inflammatory and fibrotic remodeling, and disruption of electrical conduction, which are difficult to reverse with a single therapeutic modality. Pathologically, the infarcted myocardium undergoes a sequential transition from local acidosis to oxidative/inflammatory injury and finally matrix metalloproteinase-driven scar formation. Guided by these stage-specific cues and the need to restore electrical continuity, we designed an injectable conductive hydrogel (PGO/CAM@Sal) that integrates a polypyrrole-based conductive network with pH/reactive oxygen species (ROS)/matrix metalloproteinase-9 (MMP9) triple-responsive salidroside delivery. The hydrogel matches myocardial stiffness, exhibits favorable injectability, self-healing and tissue adhesion, shows electrical conductivity comparable to native myocardium, and enables on-demand salidroside release under MI-mimicking conditions. In vitro, PGO/CAM@Sal effectively scavenges ROS, suppresses pro-inflammatory cytokine production, promotes M2 macrophage polarization and angiogenesis, and enhances connexin-43 expression and cardiomyocyte electrical coupling. In a rat MI model, local injection of PGO/CAM@Sal bridges the non-conductive infarct, stabilizes ventricular electrophysiology, improves conduction velocity and homogeneity, reduces arrhythmia vulnerability, and concurrently attenuates fibrosis, hypertrophy, and adverse left ventricular remodeling, leading to marked recovery of systolic function. Transcriptomic analysis suggests a potential involvement of the Mmp12/Cybb axis and related pathways involved in inflammation, oxidative stress, fibrosis, calcium handling, and ion transport. These molecular alterations were further validated by qRT-PCR and immunohistochemical analyses, collectively supporting the integrated therapeutic benefits observed. Accordingly, this stage-matched conductive smart hydrogel provides a comprehensive, spatiotemporally controlled strategy for precise post-MI repair.

Authors

Institutions

Publication Details

Journal
Materials Today Bio
Published
2026-03-12
DOI
https://doi.org/10.1016/j.mtbio.2026.103016
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stage-matched conductive hydrogel with pH/ROS/MMP9 triple-responsive salidroside release for post-infarction myocardial repair

Yakun Bo, Shaokai Ji, Xianhui Zhou, Heting Wu et al.
Materials Today Bio
Cardiac Fibrosis and Remodeling
article

Stage-matched conductive hydrogel with pH/ROS/MMP9 triple-responsive salidroside release for post-infarction myocardial repair

Yakun Bo, Shaokai Ji, Xianhui Zhou, Heting Wu, Yemin Chen, Jiayu He, Xing Zhang, Huanhuan Ding, Jie Song, Baopeng Tang, Zhongxiong Fan, Dilare Taiwaikuli, Chao Wang
article en

Abstract

Myocardial infarction (MI) triggers massive cardiomyocyte loss, inflammatory and fibrotic remodeling, and disruption of electrical conduction, which are difficult to reverse with a single therapeutic modality. Pathologically, the infarcted myocardium undergoes a sequential transition from local acidosis to oxidative/inflammatory injury and finally matrix metalloproteinase-driven scar formation. Guided by these stage-specific cues and the need to restore electrical continuity, we designed an injectable conductive hydrogel (PGO/CAM@Sal) that integrates a polypyrrole-based conductive network with pH/reactive oxygen species (ROS)/matrix metalloproteinase-9 (MMP9) triple-responsive salidroside delivery. The hydrogel matches myocardial stiffness, exhibits favorable injectability, self-healing and tissue adhesion, shows electrical conductivity comparable to native myocardium, and enables on-demand salidroside release under MI-mimicking conditions. In vitro, PGO/CAM@Sal effectively scavenges ROS, suppresses pro-inflammatory cytokine production, promotes M2 macrophage polarization and angiogenesis, and enhances connexin-43 expression and cardiomyocyte electrical coupling. In a rat MI model, local injection of PGO/CAM@Sal bridges the non-conductive infarct, stabilizes ventricular electrophysiology, improves conduction velocity and homogeneity, reduces arrhythmia vulnerability, and concurrently attenuates fibrosis, hypertrophy, and adverse left ventricular remodeling, leading to marked recovery of systolic function. Transcriptomic analysis suggests a potential involvement of the Mmp12/Cybb axis and related pathways involved in inflammation, oxidative stress, fibrosis, calcium handling, and ion transport. These molecular alterations were further validated by qRT-PCR and immunohistochemical analyses, collectively supporting the integrated therapeutic benefits observed. Accordingly, this stage-matched conductive smart hydrogel provides a comprehensive, spatiotemporally controlled strategy for precise post-MI repair.

Materials Today BioVol. 38
Xinjiang Medical University (CN), First Affiliated Hospital of Xinjiang Medical University (CN), Xinjiang Institute of Materia Medica (CN)
Openalex Percentile: Top 33%
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.